Laboratory Testing (May/June)

Date of Issue: 05/01/2022 | Volume: 10 | Number: 5&6

Issue Links:Learning Objectives | Editorial Information

Dr. Becker walks us through the rationale for laboratory testing in patients with substance use disorders. We provide an overview of urine toxicology testing, how it works, how to use it, and when to expect false results. Plus, a review of recent literature findings in the treatment of agitation in hospitalized patients with alcohol use disorder and the impact of opioid agonist treatments on patients with opioid use disorder.

In This Issue

Clinical Update

Urine Drug Screens: What You Need to Know

Topics: Laboratory Testing in Psychiatry | screening | Technology | urine toxicology

Urine toxicology testing is an essential tool in the treatment of patients with substance use disorders. But it can be tricky to use properly. Here, we explain the difference between a routine drug screen and confirmatory testing, and why this difference matters. We discuss when you might suspect false results and what you can do about it.

Read More
Expert Q&A

Lab Testing for Patients with Substance Use Disorders

Topics: Laboratory Testing in Psychiatry | screening | urine toxicology

Dr. Becker walks us through the ins and outs of lab testing for patients with substance use disorders. He tells us which tests are important to get at the first visit and which ones to follow over time. He also discusses how to broach the subject with patients and what to do if disagreements arise.

Read More
Research Update

Treating Agitation in ICU Patients with AUD?

Topics: Agitation | Alcohol use disorder | Delirium | Withdrawal

Patients with AUD who are hospitalized in ICUs have high rates of agitation. Researchers here investigate whether treatment with baclofen might improve outcomes.

Read More
Research Update

Opioid Agonist Treatment and Decreased Mortality

Topics: Free Articles | Medication for Opioid Use Disorder (MOUD) | Opioid epidemic | Opioid Use Disorder

Opioid agonist treatments, namely methadone and buprenorphine, save the lives of people with opioid use disorders. In this study, researchers break down how exactly these medications decrease mortality, and it’s not just by reducing overdoses.

Read More
CME Post-Test

CME Post-Test - Laboratory Testing, CATR, May/June 2022

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME Credits.

Read More